tiprankstipranks
Oncolytics Biotech (GB:0VAU)
LSE:0VAU

Oncolytics Biotech (0VAU) Stock Investors

1 Followers
Based on 732,075 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0VAU
On average, investors allocate 4.81% of their portfolios to GB:0VAU
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 732,075 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0VAU

0.8%
Last 7
Days
1.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0VAU, out of 732,075 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0VAU Investor Activity

No data currently available
Based on the activity of 13,767 investors who made their portfolios public
The table shows changes in 0VAU in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0VAU Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
3.98%
-1.13%
-3.31%
702.78M
Consumer Cyclical
GE Aerospace
5.48%
+0.47%
+7.62%
179.64B
Industrials
Plug Power
4.92%
-1.28%
-3.55%
1.87B
Industrials
Riot Platforms
5.03%
-0.07%
+3.11%
3.01B
Financial
AMC Entertainment
5.47%
-1.55%
-4.09%
912.08M
Communication Services
Merck & Company
4.13%
-0.45%
+1.55%
322.94B
Healthcare
Li Auto
5.50%
-0.43%
-2.51%
28.21B
Consumer Cyclical
Micron
5.67%
+0.11%
+4.18%
127.02B
Technology
Coherus Biosciences
2.63%
-1.50%
-5.15%
257.64M
Healthcare
Blink Charging Co
5.11%
-1.38%
-4.74%
307.01M
Industrials
Based on the activity of 732,075 active portfolios
Open your Smart Portfolio

0VAU Investor Analysis

GB:0VAU investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.6%
of GB:0VAU holders
are under 35
Average Segment Performance
Average P/E Ratio52.24
Beta6.32
Dividend Yield6.28%
GB:0VAU investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
42.1%
of GB:0VAU holders
are between 35–55
Average Segment Performance
Average P/E Ratio56.33
Beta11.09
Dividend Yield19.22%
GB:0VAU investors over 55

Over 55

3.1%
Last 30 days
Holdings Change
44.3%
of GB:0VAU holders
are over 55
Average Segment Performance
Average P/E Ratio47.15
Beta3.97
Dividend Yield6.60%
Overview of age group and performance of GB:0VAU stock investors
See who invests in 0VAU according to age group and performance.

FAQ

How many retail Investors hold GB:0VAU?
<0.1% of TipRanks' retail investors hold GB:0VAU in their portfolios.
    What is GB:0VAU Investor Sentiment?
    GB:0VAU’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of GB:0VAU in the last 7 days?
      ▲ 0.8% of TipRanks' retail investors changed their holding of GB:0VAU in the last 7 days.
        What percentage of retail investors changed their holding of GB:0VAU in the last 30 days?
        ▼ 1.1% of TipRanks' retail investors changed their holding of GB:0VAU in the last 30 days.
          What is the average age of retail investors who hold GB:0VAU?
          The average age of GB:0VAU Holders is over 55.
            What other stocks have GB:0VAU investors also bought?
            GB:0VAU Investors also bought CHPT, GE, PLUG, RIOT, AMC, MRK, LI, MU, CHRS, BLNK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              ARAYAccuray
              BAXBaxter International
              BDXBecton Dickinson
              BIIBBiogen
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis